Recent Acquisitions Selvita has been actively acquiring other companies, such as PozLab Ltd., showcasing a focus on expanding its capabilities and services. This creates opportunities for cross-selling and upselling to existing and new clients who can benefit from the extended offerings.
Strategic Partnerships Through partnerships with companies like Ardigen and NeosCreative, Selvita is entering into collaborations that can lead to joint sales efforts and access to each other's client base. Leveraging these relationships presents an avenue for expanding market reach and driving sales growth.
Cutting-Edge Technology Launches Selvita's introduction of advanced systems like the DSI Buxco nose-only inhalation and delivery exposure system demonstrates a commitment to innovation. This presents an opportunity to showcase unique technological solutions to potential clients, setting Selvita apart in the competitive landscape.
Investment in Facilities Selvita's investment in constructing its own facility indicates a focus on enhancing research and development capabilities. This investment can be leveraged as a selling point to demonstrate the company's commitment to quality and tailored solutions, attracting clients seeking advanced infrastructure and expertise.
Key Personnel Appointments With the appointment of Dean Bornilla as Vice President of Sales, Selvita is strengthening its sales leadership. This presents an opportunity for potential clients to engage with a seasoned sales professional, potentially increasing confidence in Selvita's ability to meet their needs and drive successful partnerships.
5K
$1B
132$10M$50M
10K$1B
1K
211$10M$50M
5K$1B
201
10K$1BSelvita uses 8 technology products and services including Ansible, Twitter Emoji (Twemoji), Glide.js, and more. Explore Selvita's tech stack below.
| Selvita Email Formats | Percentage |
| First.Last@selvita.com | 50% |
| First.Last@selvita.com | 50% |
Biotechnology ResearchMalopolska, Poland1001-5000 Employees
Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development.
Company Overview
Media & News
Funding & FinancialsSelvita's revenue is in the range of $100M$1B
Funding & FinancialsSelvita's revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com